Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
278 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06200376 | A Clinical Study of Intraperitoneal T3011 Given as a Single Agent in Patients With Malignant Ascites Induced by Advanced Colorectal Cancer | unknown | Phase 1 | 10 | West China HospitalOTHER | 1 | Jan 11, 2024 | clinicaltrials |
| NCT06201351 | Study of Adaptive Radiotherapy for High-grade Glioma Based on Interfraction MRI | not yet recruiting | — | 60 | West China HospitalOTHER | 1 | Jan 11, 2024 | clinicaltrials |
| NCT06172049 | Incidence of Colorectal Cancer in Southwest China: Based on SCC Database | completed | — | 5,838 | West China HospitalOTHER | 1 | Dec 15, 2023 | clinicaltrials |
| NCT06143722 | Synchronous or Sequential Radiotherapy for Advanced Esophageal Squamous Cell Carcinoma With Oligometastases. | not yet recruiting | Phase 2 | 63 | West China HospitalOTHER | 0 | Nov 22, 2023 | clinicaltrials |
| NCT06080984 | The Application of Novel Oncolytic Virus in Late Stage Solid Tumors | unknown | Phase 1 | 24 | West China HospitalOTHER | 1 | Oct 12, 2023 | clinicaltrials |
| NCT05996952 | RC48-ADC in Adjuvant/Salvage Treatment of HER2 Positive Non-muscle-invasive Bladder Cancer | unknown | Phase 2 | 77 | West China HospitalOTHER | 1 | Aug 18, 2023 | clinicaltrials |
| NCT05978609 | Cadonilimab With Chemotherapy in Treating Advanced Biliary Cancer | unknown | Phase 2 | 65 | West China HospitalOTHER | 1 | Aug 7, 2023 | clinicaltrials |
| NCT05447702 | Study of Camrelizumab Plus Apatinib and Chemotherapy as Neoadjuvant Therapy in Participants With Triple Negative Breast Cancer (TNBC) | recruiting | Phase 2 | 35 | West China HospitalOTHER | 1 | May 22, 2023 | clinicaltrials |
| NCT05640609 | Capeox Regimen Combined With Sintilimab and Bevacizumab for Gastric Cancer | recruiting | Phase 1 / Phase 2 | 57 | West China HospitalOTHER | 1 | May 16, 2023 | clinicaltrials |
| NCT05763927 | Neoadjuvant Therapy for Locally Advanced Rectal Cancer With Fruquintinib, Toripalimab and SRT | unknown | Phase 2 | 44 | West China HospitalOTHER | 1 | Mar 10, 2023 | clinicaltrials |
| NCT05738447 | Application of mRNA Immunotherapy Technology in Hepatitis B Virus-related Refractory Hepatocellular Carcinoma | unknown | Phase 1 | 9 | West China HospitalOTHER | 1 | Feb 22, 2023 | clinicaltrials |
| NCT05726175 | Disitamab Vedotin(RC48) Combined With Penpulimab(AK105) for Neoadjuvant Treatment of HER2-low Breast Cancer | unknown | Phase 2 | 20 | West China HospitalOTHER | 1 | Feb 13, 2023 | clinicaltrials |
| NCT05662813 | Almonertinib Therapy in Patients With Abnormal Liver Function After EGFR-TKI Treatment, or Almonertinib First-line Therapy in Patients With Basic Hepatopathy | unknown | Phase 2 | 55 | West China HospitalOTHER | 1 | Dec 23, 2022 | clinicaltrials |
| NCT05659186 | PD-1 Inhibitor and Anlotinib Combined With Multimodal Radiotherapy in Recurrent or Metastatic Anaplastic Thyroid Cancer | unknown | Phase 2 | 20 | West China HospitalOTHER | 1 | Dec 21, 2022 | clinicaltrials |
| NCT05600335 | Short-term Outcomes of ERAS Protocol in RAME for Esophageal Cancer | completed | — | 211 | West China HospitalOTHER | 1 | Nov 3, 2022 | clinicaltrials |
| NCT03317080 | Dynamic Monitoring Circulating Tumor DNA in Surgical Patients With Lung Cancer(LUNGCA) | unknown | — | 400 | West China HospitalOTHER | 1 | Oct 17, 2022 | clinicaltrials |
| NCT05544253 | Safety and Efficacy of Mitomycin C-based HIPEC After srHCC and PM of HCC | unknown | Phase 2 / Phase 3 | 68 | West China HospitalOTHER | 1 | Sep 16, 2022 | clinicaltrials |
| NCT05291494 | A Study on the Effectiveness of WeChat-based Online Education to Reduce Perioperative Anxiety in Breast Cancer Patients | completed | N/A | 392 | West China HospitalOTHER | 1 | Aug 31, 2022 | clinicaltrials |
| NCT04295330 | Efficacy of Intravenous Lidocaine on Postoperative Pain and Recovery in Patients Undergoing Hepatectomy | completed | N/A | 260 | West China HospitalOTHER | 1 | Aug 26, 2022 | clinicaltrials |
| NCT05430737 | A Phase II Clinical Study of Stereotactic Radiation Therapy in Patients With High-risk Prostate Cancer | unknown | N/A | 60 | West China HospitalOTHER | 1 | Jun 24, 2022 | clinicaltrials |
| NCT02342275 | Efficacy and Safety of Propranolol Versus Atenolol on the Proliferative Phase of Infantile Hemangioma | completed | Phase 3 | 377 | West China HospitalOTHER | 1 | Jun 16, 2022 | clinicaltrials |
| NCT04032860 | RCT of Different Effects of Nucleot(s)Ide Analogues on the Prognosis of HBV-HCC Patients After Curative Resection | unknown | Phase 4 | 104 | West China HospitalOTHER | 1 | May 25, 2022 | clinicaltrials |
| NCT05019534 | Tolerability and Safety of Vemurafenib, Cetuximab Combined With Camrelizumab for BRAF V600E-mutated /MSS Metastatic Colorectal Cancer | unknown | Phase 1 | 12 | West China HospitalOTHER | 1 | May 19, 2022 | clinicaltrials |
| NCT05369650 | To Explore the Safety and Efficacy of Intravenous Infusion of Different Doses of Lidocaine in Patients | unknown | N/A | 120 | West China HospitalOTHER | 1 | May 11, 2022 | clinicaltrials |
| NCT03666442 | Early Evaluation of Chemosensitivity for Low/Intermediated-risk Mid-low Stage II/III Rectal Cancer | completed | Phase 2 | 61 | West China HospitalOTHER | 1 | Apr 29, 2022 | clinicaltrials |
| NCT03188068 | Sirolimus Versus Sirolimus Plus Prednisolone for Kaposiform Hemangioendothelioma | completed | Phase 2 | 30 | West China HospitalOTHER | 1 | Apr 21, 2022 | clinicaltrials |
| NCT05299203 | BH4 in the Prevention and Treatment of Radiation-induced Skin Reactions for Head and Neck Squamous Cell Carcinoma (Including Nasopharyngeal Carcinoma) | unknown | Phase 1 | 18 | West China HospitalOTHER | 0 | Mar 28, 2022 | clinicaltrials |
| NCT05194605 | Predictive Models of Treatment Responses and Survival Outcomes in Patients With Osteosarcoma | unknown | — | 800 | West China HospitalOTHER | 1 | Jan 31, 2022 | clinicaltrials |
| NCT05187923 | Computer Aided Tool for Diagnosis of Neck Masses in Children | unknown | — | 1,500 | West China HospitalOTHER | 1 | Jan 27, 2022 | clinicaltrials |
| NCT05179850 | Computer Aided Diagnostic Tool on Computed Tomography Images for Diagnosis of Retroperitoneal Tumor in Children | unknown | — | 400 | West China HospitalOTHER | 1 | Jan 20, 2022 | clinicaltrials |
| NCT05181332 | Predictive Models of Hepatic Decompensation and Survival Outcomes in Pediatric Patients With Cirrhosis | unknown | — | 400 | West China HospitalOTHER | 1 | Jan 20, 2022 | clinicaltrials |
| NCT05171413 | Predictive Models of Treatment Responses and Survival Outcomes in Patients With Soft Tissue Sarcoma | unknown | — | 800 | West China HospitalOTHER | 1 | Dec 28, 2021 | clinicaltrials |
| NCT05170282 | Deep Learning Magnetic Resonance Imaging Radiomics for Diagnostic Value of Hepatic Tumors in Infants | unknown | — | 200 | West China HospitalOTHER | 1 | Dec 27, 2021 | clinicaltrials |
| NCT05156450 | TQB3616 Capsules Combined With Abiraterone Acetate Plus Prednisone in Metastatic Castration-Resistant Prostate Cancer | unknown | Phase 2 | 30 | West China HospitalOTHER | 1 | Dec 14, 2021 | clinicaltrials |
| NCT05018182 | FOLFOXIRI for Neoadjuvant Treatment of High-risk Locally Advanced Colorectal Cancer | unknown | Phase 2 | 69 | West China HospitalOTHER | 1 | Aug 24, 2021 | clinicaltrials |
| NCT04917770 | The Efficacy and Safety of Sintilimab in Combination With Multimodal Radiotherapy in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma | unknown | Phase 2 | 28 | West China HospitalOTHER | 0 | Jun 8, 2021 | clinicaltrials |
| NCT01437514 | Effective Study of Preoperative Short-course Radiotherapy for the Advanced Resectable Rectal Cancer | terminated | Phase 2 / Phase 3 | 410 | West China HospitalOTHER | 1 | Jun 7, 2021 | clinicaltrials |
| NCT04660617 | A Multi-omics Study of Metastatic Prostate Cancer (MOSMPCA) | unknown | — | 100 | West China HospitalOTHER | 0 | May 11, 2021 | clinicaltrials |
| NCT04865705 | Neoadjuvant Chemotherapy and Tilelizumab in Stage III（cTNM-IIIA.IIIB）Non-small-cell Lung Cancer | unknown | Phase 2 | 33 | West China HospitalOTHER | 1 | Apr 29, 2021 | clinicaltrials |
| NCT04736108 | Neoadjuvant Therapy of Abiraterone Plus ADT for Intraductal Carcinoma of the Prostate | unknown | Phase 2 | 50 | West China HospitalOTHER | 1 | Feb 8, 2021 | clinicaltrials |
| NCT02614157 | Lateral Lymph Node Dissection After Neoadjuvant Chemo-radiation in Advanced Low Rectal Cancer | terminated | N/A | 51 | West China HospitalOTHER | 1 | Feb 1, 2021 | clinicaltrials |
| NCT04646915 | Evaluation of Short-term Outcomes of Day Surgery for Patients With CuRC | unknown | — | 120 | West China HospitalOTHER | 1 | Nov 30, 2020 | clinicaltrials |
| NCT04635488 | Prediction Model for Lateral Lymph Node Metastasis | unknown | — | 200 | West China HospitalOTHER | 1 | Nov 19, 2020 | clinicaltrials |
| NCT03222024 | Cohort Study for Severe Ischaemic Stroke(SIS) | completed | — | 2,500 | West China HospitalOTHER | 1 | Oct 28, 2020 | clinicaltrials |
| NCT02718365 | Comparison Between Wedge Resection and Segmentectomy for Ground Glass Opacity- Dominant Stage IA NSCLC | unknown | N/A | 1,382 | West China HospitalOTHER | 1 | Oct 12, 2020 | clinicaltrials |
| NCT03436329 | Reduced Dissemination of Tumor Cells With Primary Ligation of the Vein in Patients With Lung Cancer | unknown | N/A | 60 | West China HospitalOTHER | 1 | Oct 12, 2020 | clinicaltrials |
| NCT04547452 | Combination of Sintilimab and Stereotactic Body Radiotherapy in Advanced Metastatic HCC | unknown | Phase 2 | 84 | West China HospitalOTHER | 1 | Sep 14, 2020 | clinicaltrials |
| NCT04414566 | Induction Chemotherapy Plus Radiotherapy Alone in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma | unknown | Phase 3 | 562 | West China HospitalOTHER | 1 | Jun 4, 2020 | clinicaltrials |
| NCT04405154 | A Study of Concomitant Camrelizumab With Chemoradiation for Locally Advanced Head and Neck Cancer | unknown | Phase 2 | 32 | West China HospitalOTHER | 0 | May 28, 2020 | clinicaltrials |
Data updated 22 days agoSource updated unknownsource: clinicaltrials